Stock A215600 SILLAJEN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases SillaJen, Inc.

Equities

A215600

KR7215600008

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 23/06/2024 BST 		5-day change 1st Jan Change
3,625 KRW +2.11% Intraday chart for SillaJen, Inc. -3.33% -39.88%
04-22 OSR Holdings and SillaJen Enter into A Memorandum of Understanding to Collaborate the Development of Innovative Therapeutics and Enter the U.S. Market CI
03-27 SillaJen, Inc. Submits CSR to the US FDA for REN026 Study in Patients with RCC CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oncolytic Virus Competitive Landscape Clinical Trials, Growth, and Key Companies | Companies- Genelux Corporation, Candel Therapeutics, CG Oncolgy, DNAtrix, SillaJen Biotherapeutics
AQ
Basilea announces transition milestone for oncology asset BAL0891 triggering milestone payment of USD 4 million by SillaJen
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A215600 Stock
  4. News SillaJen, Inc.
  5. Press Releases